MRL Ventures Fund Investor

MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.
Technology: Drug Discovery
Industry: Biotechnology, Health Care
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2014-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investor Type: Corporate Venture Capital, Venture Capital
Investment Stage: Convertible Note, Early Stage Venture, Seed, Venture
Number Of Exits: 10
Total Funding: 18735034
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-05-23
Last Funding Type: Series A

Visit Website
Register and Claim Ownership